STATE STREET CORP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$93,000
-15.5%
443,731
-1.1%
0.00%
Q2 2022$110,000
-14.1%
448,7310.0%0.00%
Q1 2022$128,000
-47.3%
448,731
+3.2%
0.00%
Q4 2021$243,000
-45.1%
434,6210.0%0.00%
Q3 2021$443,000
-29.2%
434,621
-4.1%
0.00%
Q2 2021$626,000
-73.0%
453,321
-66.8%
0.00%
Q1 2021$2,319,000
+45.0%
1,364,020
+5.8%
0.00%
Q4 2020$1,599,000
+4.2%
1,289,486
+19.3%
0.00%
Q3 2020$1,534,000
+16.1%
1,080,509
-1.1%
0.00%
Q2 2020$1,321,000
-21.2%
1,092,115
-23.1%
0.00%
Q1 2020$1,676,000
-42.7%
1,420,595
+2.5%
0.00%
Q4 2019$2,924,000
-5.3%
1,385,805
-1.3%
0.00%
Q3 2019$3,088,000
-4.0%
1,403,576
+10.4%
0.00%
Q2 2019$3,216,000
+1686.7%
1,271,167
+2351.5%
0.00%
Q1 2019$180,000
+47.5%
51,852
-1.4%
0.00%
Q4 2018$122,000
-40.5%
52,609
-1.0%
0.00%
Q3 2018$205,000
+28.1%
53,161
+12.2%
0.00%
Q2 2018$160,000
+55.3%
47,400
-3.7%
0.00%
Q1 2018$103,000
+27.2%
49,225
+23.5%
0.00%
Q4 2017$81,000
+3.8%
39,856
+137.2%
0.00%
Q3 2017$78,000
-88.6%
16,800
-94.7%
0.00%
Q2 2017$686,000
-57.6%
319,133
-37.8%
0.00%
Q1 2017$1,619,000
+27.7%
512,877
+5.1%
0.00%
Q4 2016$1,268,000
-31.5%
487,777
+2.4%
0.00%
Q3 2016$1,851,000
+62.1%
476,138
+12.1%
0.00%
Q2 2016$1,142,000
+2139.2%
424,598
+2427.4%
0.00%
Q1 2016$51,000
-21.5%
16,8000.0%0.00%
Q4 2015$65,000
+32.7%
16,800
+3.1%
0.00%
Q3 2015$49,000
-56.2%
16,300
-38.5%
0.00%
Q2 2015$112,000
-92.2%
26,500
-92.9%
0.00%
Q1 2015$1,439,000
-40.8%
372,915
+3.1%
0.00%
Q4 2014$2,430,000
+27.0%
361,872
+3.7%
0.00%
Q3 2014$1,913,000
-45.8%
348,839
+1.3%
0.00%
Q2 2014$3,528,000
-14.4%
344,396
+0.5%
0.00%
Q1 2014$4,120,000
+12.7%
342,835
+6.2%
0.00%
Q4 2013$3,655,000
+18.5%
322,956
+12.7%
0.00%
Q3 2013$3,084,000
+55.3%
286,441
+33.7%
0.00%
Q2 2013$1,986,000214,2000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders